HR 4812 · 108th Congress 2003–2005, ended

Stem Cell Discovery Through Diversity Act

Latest action · Jul 19, 2004 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 12, 2004
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Stem Cell Discovery Through Diversity Act - Requires the Director of the National Institutes of Health (NIH), acting through the national research institutes, to conduct and support research that uses human embryonic stem cells in accordance with the final guidelines issued by NIH and published in the Federal Register on August 25, 2000, including: (1) the requirements that stem cells used in research be derived from human embryos that were created in vitro for fertility treatments and were in excess of the clinical needs of the individual seeking such treatment and that such individuals voluntarily donated such embryos with informed consent; and (2) the prohibition against the use of Federal funds to derive such cells from the embryos. Provides that restrictions on such research established by the Department of Health and Human Services pursuant to policies announced by the President on August 9, 2001, have no legal effect after enactment of this Act. Prohibits additional Federal administrative policies on such research from being established or applied.

Requires the Director to ensure that such research program include a significant number of donations from individuals who are members of racial or ethnic minority groups in order to make progress toward the goal of developing an understanding of whether the variables studied in clinical research affect such groups differently.

Requires the Director to establish the Ronald Reagan Office of Human Stem Cell Research to coordinate all research conducted or supported by NIH that used human pluripotent stem cells.

Cosponsors 3

Members who signed on, in the order they did. Signatures ran from Jul 19, 2004 to Sep 9, 2004.

SeatCosponsorSigned on
D-FLAlcee L. HastingsJul 19, 2004
D-TXSheila Jackson LeeJul 19, 2004
D-VARick BoucherSep 9, 2004

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jul 12, 2004
Health Subcommittee
Referred Jul 19, 2004

Actions 3

Everything that happened, newest first.

  1. Jul 19, 2004Referred to the Subcommittee on Health.
  2. Jul 12, 2004Introduced in House
  3. Jul 12, 2004Referred to the House Committee on Energy and Commerce.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require the National Institutes of Health to conduct and support research using human embryonic stem cells, and for other purposes.
Short Titles as Introduced
Stem Cell Discovery Through Diversity Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 12, 2004Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.